CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 41 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $531,000 | -55.6% | 32,100 | -53.5% | 0.01% | -53.3% |
| Q1 2019 | $1,195,000 | -2.0% | 69,100 | 0.0% | 0.02% | -6.2% |
| Q4 2018 | $1,220,000 | -2.7% | 69,100 | 0.0% | 0.02% | +33.3% |
| Q3 2018 | $1,254,000 | -7.2% | 69,100 | 0.0% | 0.01% | -14.3% |
| Q2 2018 | $1,351,000 | +11.4% | 69,100 | 0.0% | 0.01% | +7.7% |
| Q1 2018 | $1,213,000 | +54.7% | 69,100 | 0.0% | 0.01% | +62.5% |
| Q4 2017 | $784,000 | +6.5% | 69,100 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $736,000 | +21.7% | 69,100 | 0.0% | 0.01% | +14.3% |
| Q2 2017 | $605,000 | +33.8% | 69,100 | +80.4% | 0.01% | +40.0% |
| Q1 2017 | $452,000 | -10.0% | 38,300 | 0.0% | 0.01% | -28.6% |
| Q4 2016 | $502,000 | -9.5% | 38,300 | 0.0% | 0.01% | -12.5% |
| Q3 2016 | $555,000 | – | 38,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PLATINUM INVESTMENT MANAGEMENT LTD | 672,885 | $11,123,000 | 0.26% |
| AWM Investment Company, Inc. | 80,165 | $1,325,000 | 0.25% |
| Nikko Asset Management Americas, Inc. | 532,318 | $8,799,000 | 0.17% |
| ARK Investment Management | 314,378 | $5,197,000 | 0.13% |
| Sumitomo Mitsui Trust Holdings, Inc. | 528,418 | $8,735,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 32,100 | $531,000 | 0.01% |
| Mizuho Securities Co. Ltd. | 300 | $5,000 | 0.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 148,815 | $2,459,000 | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 18,629 | $308,000 | 0.00% |
| STATE OF WISCONSIN INVESTMENT BOARD | 16,100 | $237,000 | 0.00% |